Asthma drug under ‘review’ after surge in psychiatric incidents
The medicines watchdog is finalising a review of asthma drug montelukast after a rise in Yellow Card reports, amid a shortage of other asthma drugs.
The medicines watchdog is finalising a review of asthma drug montelukast after a rise in Yellow Card reports, amid a shortage of other asthma drugs.